Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Deregulation of HLA-I in cancer and its central importance for immunotherapy.

Journal article

Hazini A. et al, (2021), J Immunother Cancer, 9

Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus.

Journal article

Wan PK-T. et al, (2021), Mol Ther, 29, 1668 - 1682

Tackling HLA Deficiencies Head on with Oncolytic Viruses.

Journal article

Fisher K. et al, (2021), Cancers (Basel), 13

Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response.

Journal article

Baugh R. et al, (2020), Cancers (Basel), 12

The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy

Journal article

Dyer A. et al, (2020), Cytokine and Growth Factor Reviews

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.

Journal article

Scott EM. et al, (2019), J Immunother Cancer, 7

Load More